BTLA mouse monoclonal antibody, clone OTI1B4 (formerly 1B4)
Applications | WB |
Reactivities | Human |
BTLA mouse monoclonal antibody, clone OTI1B4 (formerly 1B4)
Applications | WB |
Reactivities | Human |
BTLA mouse monoclonal antibody, clone OTI2F5 (formerly 2F5)
Applications | WB |
Reactivities | Human |
BTLA mouse monoclonal antibody, clone OTI3E10 (formerly 3E10)
Applications | WB |
Reactivities | Human |
BTLA - human gene knockout kit via CRISPR, HDR mediated
Format | 2 gRNA vectors, 1 GFP-puro donor, 1 scramble control |
Donor DNA | GFP-puro |
BTLA - human gene knockout kit via CRISPR, HDR mediated
Format | 2 gRNA vectors, 1 Luciferase-Puro donor, 1 scramble control |
Donor DNA | Luciferase-Puro |
BTLA - human gene knockout kit via CRISPR, HDR mediated
Format | 2 gRNA vectors, 1 RFP-BSD donor, 1 scramble control |
Donor DNA | RFP-BSD |
BTLA - human gene knockout kit via CRISPR, HDR mediated
Format | 2 gRNA vectors, 1 mBFP-Neo donor, 1 scramble control |
Donor DNA | mBFP-Neo |
Transient overexpression lysate of B and T lymphocyte associated (BTLA), transcript variant 2
Tag | C-Myc/DDK |
Expression Host | HEK293T |
Transient overexpression of BTLA, transcript variant 1, in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
Transient overexpression of BTLA, transcript variant 2, in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
BTLA - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
Format | Retroviral plasmids |
Vector | pRS |
Rabbit Polyclonal Anti-BTLA Antibody
Applications | IHC, WB |
Reactivities | Human |
Rabbit Polyclonal Anti-BTLA Antibody
Applications | IHC, WB |
Reactivities | Human |
Rabbit polyclonal antibody to CD272 (B and T lymphocyte associated)
Applications | IHC, WB |
Reactivities | Human |
Goat Anti-BTLA Antibody
Applications | WB |
Reactivities | Mouse (Expected from sequence similarity: Human, Rat) |